Evestra, Inc.
PrivateLast Round
Grant
Sep 6, 2022
Total Funding Raised
$23M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Evestra, Inc. is a biopharmaceutical company that develops innovative products in women's healthcare and oncology using steroid medicinal chemistry and vaginal drug delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evestra, Inc. Comparables
Compare Evestra, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VaRi Bioscience GmbH | 81% | |
| AnelleO | 78% | |
| Daré Bioscience Inc | 76% |
Evestra, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 6, 2022 | ||||
| Grant | Mar 30, 2022 | ||||
| Grant | Nov 1, 2020 | ||||
| Strategic | Jul 22, 2019 | ||||
| Grant | Jan 24, 2017 | ||||
Seed | May 12, 2008 |
Evestra, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| Gates Foundation | Grant |
| European Regional Development Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 187% MoM, reaching 2.5K.
- Nov 10, 2025
Monthly visitors increased 53% MoM.
Evestra, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evestra, Inc.'s valuation, stock price, and market status.
Is Evestra, Inc. a public or private company?
Evestra, Inc. is a private company.
What is the current stock price of Evestra, Inc.?
Evestra, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Evestra, Inc. worth (valuation)?
Valuation information for Evestra, Inc. is not publicly available.
Can I buy Evestra, Inc. stock?
Evestra, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evestra, Inc.'s last funding round?
Evestra, Inc.'s most recent funding round was Grant on September 6, 2022.
Who are the main investors in Evestra, Inc.?
Key investors in Evestra, Inc. include United States Department of Defense, NIH RADx, Gates Foundation, European Regional Development Fund.
Will Evestra, Inc. IPO soon?
No public IPO plans have been announced for Evestra, Inc..
How can I track Evestra, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evestra, Inc.'s secondary market activity and sign up for updates.